CompletedPhase 3NCT00711295
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
Studying Avian influenza
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alachua Government Services, Inc.
- Principal Investigator
- Baxter Bio Science InvestigatorBaxter Healthcare Corporation
- Intervention
- H5N1 Influenza Vaccine Whole virion, Vero cell-derived, Inactivated Influenza Vaccine, non-adjuvanted(biological)
- Enrollment
- 3583 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2008 – 2010
Study locations (30)
- Allgemeines Krankenhaus Wien, Innere Medizin, Waehringer Guertel 18-20, Vienna, Austria
- Institut für spezifische Prophylaxe und Tropenmedizin, Kinderspitalgasse 15, Vienna, Austria
- University Clinic for Clinical Pharmacology, Vienna Medical University / Vienna General Hospital, Waehringer Guertel 18-20, Vienna, Austria
- OLV Hospital Aalst, Research Unit, Moorselbaan 164, Aalst, Belgium
- Cliniques Universitaires Saint Luc, Avenue Hippocrate 10, Niveau -1 Couloir C11, Brussels, Belgium
- Center for Vaccinologie, UZ Gent, De Pintelaan 185, Ghent, Belgium
- UZ Leuven, Kapucijnenvoer 35, Block D, Box 7001, Leuven, Belgium
- UZ Antwerpen, Universiteitsplein 1, Wilrijk, Belgium
- Espoon rokotetutkimusklinikka, Keskustorni 7. krs., Tapiontori 1, Espoo, Finland
- Etelä-Helsingin rokotetutkimusklinikka, Vuorikatu 18, 3 krs, Helsinki, Finland
- Tampereen rokotetutkimusklinikka, Pinninkatu 47, 1.krs, Tampere, Finland
- Turun rokotetutkimusklinikka, Lemminkäisenkatu 14-18 B, 4.krs, Turku, Finland
- Itä-Vantaan rokotetutkimusklinikka, Asematie 11 A 16, Vantaa, Finland
- Charité - Universitaetsmedizin Berlin, Medizinische Klinik III, Haematologie, Onkologie & Transfusionsmedizin, Karl Landsteiner-Haus, 1 OG, Hindenburgdamm 30, Berlin, Germany
- Klinische Forschung Berlin Buch GmbH, Robert-Rössle-Str. 10 / Haus 85, Berlin, Germany
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00711295 on ClinicalTrials.govOther trials for Avian influenza
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07496450A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy AdultsModernaTX, Inc.
- RECRUITINGPHASE3NCT07240558Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)University Health Network, Toronto
- ACTIVE NOT RECRUITINGPHASE4NCT07275060Immunogenicity and Safety of 2 Doses of Avian Influenza A (H5N1) Vaccine Administered 3 vs. 8 Weeks ApartCanadian Immunization Research Network
- RECRUITINGPHASE1, PHASE2NCT06842173Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older AdultsButantan Institute
- ACTIVE NOT RECRUITINGPHASE1NCT07019883A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy AdultsNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNANCT06850298H5N1 Milk Detection StudyEmory University